Richard Glickman

Richard Glickman

Presidente en ENGENE HOLDINGS INC. .

Fortuna: 529 576 $ al 31/05/2024

65 años
Health Technology
Finance
Commercial Services

Perfil

Richard M.
Glickman
founded Aurinia Pharmaceuticals, Inc. in 1993, where he worked as Chairman & Chief Executive Officer from 2013 to 2019 and Aspreva Pharmaceuticals Corp.
in 2001, where he worked as Chairman & Chief Executive Officer from 2001 to 2006.
Dr. Glickman also founded Probtec Corp., Nventa Biopharmaceuticals Corp., where he worked as Chief Executive Officer, Stressgen Biotechnologies Corp., where he worked as Chief Executive Officer, Ontario Molecular Diagnostics, where he worked as Director, Aurinia Pharmaceuticals, Inc., where he worked as Chief Executive Officer, and Aurinia Pharma Corp., where he worked as Chairman & Chief Executive Officer from 2017 to 2019.
Dr. Glickman also currently works at ESSA Pharma, Inc., as Chairman from 2010, enGene Holdings, Inc., as Chairman from 2024, MedGenesis Therapeutix, Inc., as Director, enGene, Inc., as Director from 2011, Eupraxia Pharmaceuticals, Inc., as Director from 2021, Vida Pharmaceuticals Pvt Ltd., as Director, Eurpraxia Pharmaceuticals, Inc., as Director, and Lumira Capital Investment Management, Inc., as Venture Partner.
Dr. Glickman also formerly worked at Vigil Health Solutions, Inc., as Chairman, LifeSciences British Columbia, as Chairman, BC Biotech, as Chairman, Correvio Pharma Corp., as Lead Independent Director, Canadian Genetic Disease Network, as Director, Vancouver Aquarium, as Director, viDA Therapeutics, Inc., as Director, Innovate BC, as Member, and Kearny Venture Partners, as Venture Partner.
Dr. Glickman received his undergraduate degree from McGill University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/04/2024 43 240 ( 0.10% ) 291 870 $ 31/05/2024
15/06/2024 24 675 ( 0.06% ) 216 893 $ 31/05/2024
13/05/2024 7 680 ( 0.02% ) 20 813 $ 31/05/2024

Cargos activos de Richard Glickman

EmpresasCargoInicio
ESSA PHARMA INC. Presidente 01/10/2010
EUPRAXIA PHARMACEUTICALS INC. Director/Miembro de la Junta 09/03/2021
ENGENE HOLDINGS INC. Presidente 15/05/2024
Inversor de Capital Privado -
Vida Pharmaceuticals Pvt Ltd. Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta 23/09/2011
Todos los cargos activos de Richard Glickman

Antiguos cargos conocidos de Richard Glickman.

EmpresasCargoFin
AURINIA PHARMACEUTICALS INC. Director Ejecutivo 29/04/2019
Director Ejecutivo 01/01/2019
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
░░░░░░░ ░░░░░ ░░░░░░░░ -
Ver el detalle de la experiencia de Richard Glickman.

Formación de Richard Glickman.

McGill University Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Richard Glickman.

Relaciones

100 +

Relaciones de 1er grado

25

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas4
EUPRAXIA PHARMACEUTICALS INC.

Health Technology

ESSA PHARMA INC.

Health Technology

AURINIA PHARMACEUTICALS INC.

Health Technology

ENGENE HOLDINGS INC.

Health Technology

Empresas privadas20

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Finance

Stressgen Biotechnologies Corp. /Bioreagents Business/

Health Technology

Commercial Services

Health Technology

Canadian Genetic Disease Network

Finance

Commercial Services

Miscellaneous

Health Technology

Ontario Molecular Diagnostics

Probtec Corp.

Aurinia Pharmaceuticals, Inc. /Old/

Health Technology

Retail Trade

Vida Pharmaceuticals Pvt Ltd.

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Richard Glickman